Outcomes of skin graft reconstructions with the use of Vacuum Assisted Closure (VAC ® ) dressing for irradiated extremity sarcoma defects
Johnson Craig H, Moran Steven L, Knoetgen James and 3 more
World Journal of Surgical Oncology · 2007
doi:10.1186/1477-7819-5-138 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
BACKGROUND: Flaps are currently the predominant method of reconstruction for irradiated wounds. The usefulness of split-thickness skin grafts (STSG) in this setting remains controversial. The purpose of this study is to examine the outcomes of STSGs in conjunction with VAC therapy used in the treatment of irradiated extremity wounds. METHODS: The records of 17 preoperatively radiated patients with extremity sarcomas reconstructed with STSGs in conjunction with VAC(R) therapy were reviewed regarding details of radiation treatment, wound closure, and outcomes. RESULTS: STSGs healed without complications (>95% of the graft take) in 12 (71%). Minor loss (6% - 20% surface) was noted in 3 patients (17.6%) and complete loss in 2 (11.7%). Two patients (11.7%) required flap reconstructions and 12 (88%) healed without further operative procedures. CONCLUSION: Although flap coverage is an established treatment for radiated wounds, STSG in conjunction with liberal utilization of VAC therapy is an alternative for selected patients where acceptable soft tissue bed is preserved. Healing of the preoperatively radiated wounds can be achieved in the vast majority of such patients with minimal need for additional reconstructive operations.
Abstract licence: CC BY-NC-ND
References43
43 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.